{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:21:17Z","timestamp":1793996477228,"version":"4.8.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"abstract":"<jats:p>\n                    The incidence of inflammatory bowel disease (IBD) and metabolic syndrome (MetS) has risen in recent years, but the relationship between the 2 remains understudied. This retrospective cohort study aimed to explore the impact of MetS on disease activity in IBD. Retrospective analysis of 676 consecutive IBD patients treated from January 2023 to April 2024. Study participants were stratified into a control cohort of 531 patients with uncomplicated IBD, and an exposure cohort of 145 patients with IBD and concurrent MetS. Data were collected and analyzed for all 676 patients at baseline and after 1-year follow-up. From an initial pool of 1730 potentially eligible patients, 156 (9%) were identified with MetS (IBD-MetS cohort: 86% ulcerative colitis and 14% Crohn\u2019s disease). Baseline clinical disease activity was significantly higher than in the IBD-only controls, with concomitant elevations in biomarkers including monocytosis, eosinophilia, elevated C-reactive protein and elevated erythrocyte sedimentation rate. At 12-months\u2019 follow-up, the IBD-MetS group showed significantly lower rates of clinical remission (54.48% vs 82.49%) and mucosal healing (24.83% vs 41.05%) compared to the controls. Inflammatory biomarkers remained elevated, consistent with baseline findings. After propensity score-matched analysis, a comparative analysis of 145 matched controls and 145 exposed groups showed that, compared to IBD-only patients, IBD-MetS patients still had significantly lower rates of clinical remission (54.48% vs 77.93%, odds ratio: 0.339, 95% confidence interval: 0.203\u20130.565,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and mucosal healing (24.83% vs 41.38%, odds ratio: 0.468, 95% confidence interval: 0.283\u20130.772,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.003). Our findings indicate that MetS is correlated with increased disease activity in IBD. These findings emphasize the need for clinicians to identify and intervene in metabolic syndrome components in IBD patients, ultimately improving quality of life and providing new insights for future IBD-MetS research.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048426","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:02:50Z","timestamp":1777273370000},"page":"e48426","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Influence of metabolic syndrome on disease characteristics and activity in inflammatory bowel disease: A retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"given":"Pingping","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6957-1811","authenticated-orcid":false,"given":"Xue","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7901-1292","authenticated-orcid":false,"given":"Lingling","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9068-6688","authenticated-orcid":false,"given":"Shijin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4594-8267","authenticated-orcid":false,"given":"Jingli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4021-2246","authenticated-orcid":false,"given":"Xueli","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2494-1871","authenticated-orcid":false,"given":"Lijuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7244-7894","authenticated-orcid":false,"given":"Beibei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260622","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications.","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"R2-20260622","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease.","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"R3-20260622","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","article-title":"Crohn\u2019s disease.","volume":"403","author":"Dolinger","year":"2024","journal-title":"Lancet (London, England)"},{"key":"R4-20260622","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis.","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet (London, England)"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jgh.14872","article-title":"The epidemiology of inflammatory bowel disease: East meets west.","volume":"35","author":"Mak","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"R6-20260622","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/S0140-6736(17)32669-7","article-title":"Rapid changes in epidemiology of inflammatory bowel disease.","volume":"390","author":"Kamm","year":"2017","journal-title":"Lancet (London, England)"},{"key":"R7-20260622","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The Global Epidemic of the Metabolic Syndrome.","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"R8-20260622","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(05)66375-1","article-title":"Prevalence of the metabolic syndrome and overweight among adults in China.","volume":"365","author":"Gu","year":"2005","journal-title":"Lancet (London, England)"},{"key":"R9-20260622","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.3390\/nu13124475","article-title":"Prevalence and Influencing Factors of Metabolic Syndrome among Adults in China from 2015 to 2017.","volume":"13","author":"Yao","year":"2021","journal-title":"Nutrients"},{"key":"R10-20260622","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s41043-025-00860-z","article-title":"Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a meta-analysis on a global scale.","volume":"44","author":"Janani","year":"2025","journal-title":"J Health Popul Nutr"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/gutjnl-2024-331914","article-title":"Heavy arch: from inflammatory bowel diseases to metabolic disorders.","volume":"73","author":"Adolph","year":"2024","journal-title":"Gut"},{"key":"R12-20260622","doi-asserted-by":"crossref","first-page":"109365","DOI":"10.1016\/j.compbiomed.2024.109365","article-title":"Integrative multi-omics analysis of Crohn\u2019s disease and metabolic syndrome: Unveiling the underlying molecular mechanisms of comorbidity.","volume":"184","author":"Ding","year":"2025","journal-title":"Comput Biol Med"},{"key":"R13-20260622","doi-asserted-by":"crossref","first-page":"630","DOI":"10.14309\/ajg.0000000000000197","article-title":"Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases.","volume":"114","author":"Jain","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ibd\/izz305","article-title":"Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus.","volume":"26","author":"Din","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"R15-20260622","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.3748\/wjg.v25.i43.6465","article-title":"Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression.","volume":"25","author":"Jovanovic","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R16-20260622","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1620\/tjem.254.171","article-title":"Increased Severity of Ulcerative Colitis in the Terminal Phase of the Metabolic Syndrome.","volume":"254","author":"Jovanovic","year":"2021","journal-title":"Tohoku J Exp Med"},{"key":"R17-20260622","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000380763","article-title":"Impact of metabolic syndrome on the hospitalization rate of Crohn\u2019s disease patients seen at a tertiary care center: a retrospective cohort study.","volume":"91","author":"Fitzmorris","year":"2015","journal-title":"Digestion"},{"key":"R18-20260622","first-page":"1647","article-title":"Chinese national clinical practice guideline on diagnosis and management of Crohn\u2019s disease.","volume":"137","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"R19-20260622","first-page":"1642","article-title":"Chinese national clinical practice guideline on diagnosis and management of ulcerative colitis.","volume":"137","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"R20-20260622","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition.","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R21-20260622","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4158\/EP.9.S2.5","article-title":"American College of Endocrinology position statement on the insulin resistance syndrome.","volume":"9","author":"Einhorn","year":"2003","journal-title":"Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"key":"R22-20260622","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"R23-20260622","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"R24-20260622","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease.","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet (London, England)"},{"key":"R25-20260622","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/ecco-jcc\/jjv111","article-title":"The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.","volume":"9","author":"Lobat\u00f3n","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R26-20260622","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis.","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"R27-20260622","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study.","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"R28-20260622","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.","volume":"132","author":"D\u2019Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"R29-20260622","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD.","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R30-20260622","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabetic medicine : a journal of the British Diabetic Association"},{"key":"R31-20260622","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10654-011-9554-9","article-title":"Estimating measures of interaction on an additive scale for preventive exposures.","volume":"26","author":"Knol","year":"2011","journal-title":"Eur J Epidemiol"},{"key":"R32-20260622","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40259-022-00522-0","article-title":"Impact of Obesity on Response to Biologic Therapies in Patients with Inflammatory Bowel Diseases.","volume":"36","author":"Bassi","year":"2022","journal-title":"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy"},{"key":"R33-20260622","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/ecco-jcc\/jjab088","article-title":"Obesity in Inflammatory Bowel Disease Is Associated with Early Readmissions Characterised by an Increased Systems and Patient-level Burden.","volume":"15","author":"Weissman","year":"2021","journal-title":"J Crohns Colitis"},{"key":"R34-20260622","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.dld.2022.08.017","article-title":"Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis.","volume":"55","author":"Fuschillo","year":"2023","journal-title":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"key":"R35-20260622","first-page":"e16566","article-title":"In-Hospital Outcomes of Inflammatory Bowel Diseases in Patients With Diabetes Mellitus: A Propensity Score Matching Analysis.","volume":"13","author":"Uwagbale","year":"2021","journal-title":"Cureus"},{"key":"R36-20260622","doi-asserted-by":"crossref","first-page":"e0334456","DOI":"10.1371\/journal.pone.0334456","article-title":"Investigating the common genetic basis between inflammatory bowel disease and metabolic syndrome through genomic structural equation modeling.","volume":"20","author":"Shen","year":"2025","journal-title":"PLoS One"},{"key":"R37-20260622","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-nutr-071811-150623","article-title":"Mechanisms of inflammatory responses in obese adipose tissue.","volume":"32","author":"Sun","year":"2012","journal-title":"Annu Rev Nutr"},{"key":"R38-20260622","first-page":"771","article-title":"Responses of adipose and muscle lipoprotein lipase to chronic infection and subsequent acute lipopolysaccharide challenge.","volume":"9","author":"Picard","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"R39-20260622","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ejcn.2012.103","article-title":"The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study.","volume":"66","author":"Leber","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"R40-20260622","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R41-20260622","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/eje.1.02338","article-title":"Plasma resistin levels correlate with determinants of the metabolic syndrome.","volume":"156","author":"Norata","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R42-20260622","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/S1807-59322006000500010","article-title":"Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome.","volume":"61","author":"Bahia","year":"2006","journal-title":"Clinics (Sao Paulo, Brazil)"},{"key":"R43-20260622","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1210\/jc.2003-031826","article-title":"Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction.","volume":"89","author":"Xydakis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-20260622","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/oby.2006.248","article-title":"Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults.","volume":"14","author":"Van Guilder","year":"2006","journal-title":"Obesity (Silver Spring, Md.)"},{"key":"R45-20260622","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.diabres.2006.06.019","article-title":"Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome.","volume":"75","author":"Choi","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"R46-20260622","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.ejcn.1602384","article-title":"Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.","volume":"60","author":"Gonz\u00e1lez","year":"2006","journal-title":"Eur J Clin Nutr"},{"key":"R47-20260622","doi-asserted-by":"crossref","first-page":"585887","DOI":"10.3389\/fendo.2021.585887","article-title":"Leptin and Obesity: Role and Clinical Implication.","volume":"12","author":"Obradovic","year":"2021","journal-title":"Front Endocrinol"},{"key":"R48-20260622","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"R49-20260622","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.ATV.0000163843.70369.12","article-title":"Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance.","volume":"25","author":"Hung","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R50-20260622","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.4155\/fmc.10.265","article-title":"Adipokines have a role to play in the treatment of metabolic disease.","volume":"2","author":"Russell","year":"2010","journal-title":"Future Med Chem"},{"key":"R51-20260622","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MOG.0000000000000116","article-title":"Role of fat and adipokines in intestinal inflammation.","volume":"30","author":"Kredel","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"R52-20260622","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2249.2012.04660.x","article-title":"Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn\u2019s disease.","volume":"170","author":"Rodrigues","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"R53-20260622","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MIB.0000000000000209","article-title":"Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel.","volume":"21","author":"Gon\u00e7alves","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"R54-20260622","doi-asserted-by":"crossref","first-page":"920S","DOI":"10.3945\/jn.115.218487","article-title":"Protective Effects of the Mediterranean Diet on Type 2 Diabetes and Metabolic Syndrome.","volume":"146","author":"Salas-Salvad\u00f3","year":"2015","journal-title":"J Nutr"},{"key":"R55-20260622","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3390\/nu12051434","article-title":"Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites.","volume":"12","author":"Verdugo-Meza","year":"2020","journal-title":"Nutrients"},{"key":"R56-20260622","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage.","volume":"101","author":"B\u00e4ckhed","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R57-20260622","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers.","volume":"500","author":"Le Chatelier","year":"2013","journal-title":"Nature"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:01:34Z","timestamp":1782151294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":57,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048426","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"2025-09-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}